Andrew McLean

Andrew McLean is currently the Managing Partner at Tin Alley Ventures. Previously, Andrew worked as a Strategy Consultant at Reverent Health, where Andrew supported small to mid-size biotech and healthtech companies on fundraising, strategy, and portfolio optimization. Andrew also held various board positions at companies such as Theolytics, PepGen, Evox Therapeutics Ltd, MiroBio Ltd, Scenic Biotech, DJS Antibodies, and Osler Diagnostics. With a background in Philosophy, Politics, Economics, and Medicine, Andrew is well-versed in the healthcare and life sciences industries.